BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Linepemat (IRL757) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Linepemat (IRL757)\, from ClinicalTrials.
 gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07461220-1659@assetmemo.bio
DTSTAMP:20261121T010149Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:Linepemat (IRL757): Phase 1/2 readout est. (NCT07461220)
DESCRIPTION:Linepemat (IRL757)\, phase 1/2\, Parkinson's Disease.\nStudy: S
 afety and Tolerability of IRL757 in Participants With Parkinson's Disease 
 and Apathy\nEstimated primary completion: May 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/linepemat-irl757#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT07461220
URL:https://assetmemo.bio/drug/linepemat-irl757#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
